Haystack

Next-Generation Solutions for Drug Discovery

DyNAbind GmbH

is a privately-held biotech company from Dresden offering partnerships and solutions for better drug discovery with Dynamic DNA-Encoded Library (D-DEL) technologies.

We have overhauled the DEL discovery process by introducing proprietary innovations in library design, selection and validation, all of which lead to a faster path to high-quality, relevant starting points for medicinal chemistry – and the only DEL platform on the market fully designed to integrate with a fragment-based discovery methodology.

Groups of all sizes are welcome to contact us for more information on potential partnerships! Let us show you how our technologies and programs can de-risk and accelerate your discovery campaigns and put you on the path to better medicinal chemistry start points.